KCAT	Arachis hypogaea	0.26	ATP	*recombinant mutant Y317F
KCAT	Arachis hypogaea	0.54	ATP	*recombinant mutant Y297F
KCAT	Arachis hypogaea	1.02	ATP	*recombinant mutant Y148F
KCAT	Arachis hypogaea	3.09	histone H1	*recombinant mutant Y148F
KCAT	Arachis hypogaea	3.3	histone H1	*recombinant mutant Y317F
KCAT	Arachis hypogaea	3.71	histone H1	*recombinant mutant Y297F
KCAT	Arachis hypogaea	4.74	histone H1	*recombinant mutant Y317F
KCAT	Arachis hypogaea	5.25	ATP	*recombinant wild-type enzyme
KCAT	Arachis hypogaea	14.5	ATP	*recombinant mutant Y213F
KCAT	Arachis hypogaea	18.4	histone H1	*recombinant mutant Y213F
KM	Arachis hypogaea	-999	more	*kinetics
KM	Homo sapiens	-999	more	*Michaelis-Menten kinetics; Michaelis-Menten kinetics
KM	Arachis hypogaea	0.006	histone H1	*recombinant mutant Y213F
KM	Arachis hypogaea	0.007	histone H1	*recombinant wild-type enzyme
KM	Arachis hypogaea	0.009	histone H1	*recombinant wild-type enzyme
KM	Arachis hypogaea	0.011	histone H1	*recombinant mutants Y148F and Y297F
KM	Arachis hypogaea	0.012	histone H1	*recombinant mutant Y317F
KM	Arachis hypogaea	0.019	ATP	*recombinant mutant Y213F
KM	Arachis hypogaea	0.034	ATP	*recombinant wild-type enzyme
KM	Arachis hypogaea	0.059	ATP	*recombinant mutant Y317F
KM	Homo sapiens	0.0807	ATP	*pH 6.8, 22&deg;C
KM	Arachis hypogaea	0.081	ATP	*recombinant mutant Y297F
KM	Arachis hypogaea	0.107	ATP	*recombinant mutant Y148F
KM	Homo sapiens	0.1185	ATP	*pH 6.8, 22&deg;C
MW	Arachis hypogaea	55000	*	*recombinant His-tagged wild-type enzyme, gel filtration
MW	Mus musculus	65000	*	*x * 65000, splicing variant 1, SDS-PAGE, x * 70000, splicing variant 2, SDS-PAGE, x * 75000, splicing variant 3 from skeletal muscle, SDS-PAGE
MW	Mus musculus	70000	*	*x * 65000, splicing variant 1, SDS-PAGE, x * 70000, splicing variant 2, SDS-PAGE, x * 75000, splicing variant 3 from skeletal muscle, SDS-PAGE
MW	Mus musculus	75000	*	*x * 65000, splicing variant 1, SDS-PAGE, x * 70000, splicing variant 2, SDS-PAGE, x * 75000, splicing variant 3 from skeletal muscle, SDS-PAGE
MW	Rattus norvegicus	90000	*	*SDS-PAGE
SA	Saccharomyces cerevisiae	-999	*	*large scale activity assay with recombinant enzyme in a protein chip consisting of a microwell array with protein covalently attached to the wells via a 3-glycidoxypropyltrimethoxysilane crosslinker, overview
SA	Homo sapiens	-999	*	*presence of an extra copy of the Dyrk1A gene due to trisomy 21 results in overexpression of Dyrk1A and elevated kinase activity in brain of Down syndrome patients, tau phosphorylation, enzyme kinetics, and Dyrk1A kinase assays, nuclear and cytoplasmic Dyrk1A may contribute to Down syndrome via different mechanisms
SA	Homo sapiens	-999	*	*stabilization of viral oncoproteins E6 and E7 of HPV16 by phosphorylation the threonine 5 and threonine 7 residues, substitution mutations, in vitro and in vivo interaction with HPV16E7, half-life of E7 protein extended by replacing threonine 5 and 7 residues with aspartic acid, DYRK1A-induced phosphorylation protects E7 from degradation, as a consequence inactivation of the tumor suppressor pRb is increased
SA	Homo sapiens	-999	*	*imbalance of 3R-tau and 4R-tau proteins attributed to Dyrk1A-induced dysregulation of alternative splicing factor (ASF), Dyrk1A phosphorylates alternative splicing factor (ASF) at Ser-227, Ser-234, and Ser-238, Dyrk1A inhibits the role of alternative splicing factor (ASF) in tau exon 10 inclusion, splicing of exon 10 of tau protein quantified, interaction between alternative splicing factor (ASF) and Dyrk1A, model for the inhibitory role of Dyrk1A in tau exon 10 inclusion via phosphorylation of ASF
SA	Mus musculus	-999	*	*increased reticulocyte production in DYRK3-knockout mice in response to hemolytic anemia due to DYRK3 deficiency, elevated reticulocyte and red cell formation in DYRK3-knockout mice after 5-fluorouracil-induced anemia, short term transplant experiments, DYRK3-knockout progenitors support enhanced erythroblast formation, erythropoietic advantages due to DYRK3-deficiency observed in 5-fluorouracil-treated mice expressing a compromised erythropoietin receptor EPOR-HM allele, transgenic pA2gata1-DYRK3 mice produce fewer reticulocytes during hemolytic anemia, pA2gata1-DYRK3 progenitors compromised in late pro-erythroblast formation ex vivo, DYRK3 inhibits transcriptional response pathways mediated by nuclear factor of activated T cells (NFAT) in erythroid K562 cells
SA	Homo sapiens	-999	*	*phosphorylation of the beta-amyloid (Ab) precursor protein APP at the threonine residue 668 by DYRK1A shown in vitro and in mammalian cells, overexpression of the human DYRK1A protein in transgenic mice reveals increased amounts of phophorylated APP precursor protein, increased amounts of phosphorylated APP precursor protein in brains of Down syndrome patients
SA	Mus musculus	-999	*	*mice heterozygous for a Dyrk1A targeted mutation (Dyrk1A+/2) and wild-type, behavioral tests, non-searching and learning strategies in the Morris water maze test, swimming test, object recognition test, profound effect on phenotype by removal of single gene, haploinsufficiency of DYRK1A might contribute to an impairment of cognitive functions and stress coping behavior in human monosomy 21
